Association between obesity and therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia

Postgraduate Medicine

Volumn 126, Issue 1, 2014, Pages 66-77

  Chopra, Ishveen ^a   Kamal, Khalid M ^a   Candrilli, Sean D ^b   Kanyongo, Gibbs ^a  

^a DUQUESNE UNIVERSITY   (United States)

^b RTI HEALTH SOLUTIONS   (United States)

Author keywords

Blood pressure; Body mass index; Goal attainment; Lipid; Obesity

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL; LIPID;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDY; SMOKING; ADOLESCENT; AGE; BLOOD; BLOOD PRESSURE; COMORBIDITY; RISK FACTOR; SOCIOECONOMICS; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BODY MASS INDEX; COMORBIDITY; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; HYPOLIPIDEMIC AGENTS; LIPIDS; MALE; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDIES; RISK FACTORS; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84897018979     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2014.01.2726     Document Type: Article

References (24)

1. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303(3):235–241.
2. Jia H, Lubetkin EI. The impact of obesity on health-related quality-of-life in the general adult US population. J Public Health. 2005;27(2):156–164.
3. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. National Heart Lung and Blood Institute website. http://www.nhlbi.nih.gov/guidelines/obesity/ob_home.htm.
4. Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer and service-specific estimates. Health Affairs. 2009;28(5):w822–w831.
5. Hammond RA, Levine R. The economic impact of obesity in the United States. Diabetes Metab Syndr Obes. 2010;3:285–295.
6. Nash DT. The clinical implications and management of concomitant hypertension and dyslipidemia. Postgrad Med. 2006;119(2):37–45.
7. Ferdinand KC, Kleinpeter, MA. Management of hypertension and dyslipidemia. Curr Hypertens Rep. 2006;8(6):489–496.
8. Bays HE, Chapman RH, Grandy S. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int J Clin Pract. 2007;61(5):737–747.
9. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–2497.
10. Brown CD, Higgins M, Donato KA, et al. Body mass index and prevalence of hypertension and dyslipidemia. Obes Res. 2000;8(9):605–619.
11. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19): 2560–2571.
12. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. Lancet. 2001;357(9261):995–1001.
13. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA. 2003;290(2):199–206.
14. Dubois RW, Alexander CM, Wade S, et al. Growth in use of lipid lowering therapies: are we targeting the right patients? Am J Manag Care. 2002;8(10):862–867.
15. Pearson TA, Laurora I, Chu H, Kafonek S. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med. 2000;160(4): 459–467.
16. Ford ES, Mokdad AH, Giles WH, Mensah GA. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation. 2003; 107(17):2185–2189.
17. Selby JV, Lee J, Swain BE, et al. Trends in time to confirmation and recognition of new-onset hypertension, 2002–2006. Hypertension. 2010;56(4):605–611.
18. Vital signs: state-specific obesity prevalence among adults—United States, 2009. Centers for Disease Control and Prevention website. http:// www.cdc.gov/mmwr.
19. Krauss RM, Winston M, Fletcher BJ, Grundy SM. Obesity: impact on cardiovascular disease. Circulation. 1998;98(14):1472–1476.
20. Narkiewicz K. Obesity and hypertension—the issue is more complex than we thought. Nephrol Dial Transplant. 2006;21(2):264–267.
21. Selby JV, Tiffany P, Karter AJ, et al. High rates of co-occurrence of hypertension, elevated low-density lipoprotein cholesterol, and diabetes mellitus in a large managed care population. Am J Manag Care. 2004; 10(2 Pt 2):163–170.
22. Biskupiak JE, Kim J, Phatak H, Wu D. Prevalence of high-risk cardiovascular conditions and the status of hypertension management among hypertensive adults 65 years and older in the united states: analysis of a primary care electronic medical records database. J Clin Hypertens (Greenwich). 2010;12(12):935–944.
23. Choe HM, Townsend KA, Blount G, Lo CH, Sadowski L, Standiford CJ. Treatment and control of blood pressure in patients with diabetes mellitus. Am J Health Syst Pharm. 2007;64(1):97–103.
24. Shelley D, Tseng TY, Andrews H, et al. Predictors of blood pressure control among hypertensives in community health centers. Am J Hypertens. 2011;24(12):1318–1323.